Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans biofilm persisters

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 10, 2015, Pages 6101-6112

  Li, Peng ^a   Seneviratne, Chaminda J ^b   Alpi, Emanuele ^c   Vizcaino, Juan A ^c   Jin, Lijian ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GLYOXYLIC ACID; ISOCITRATE LYASE; MALATE SYNTHASE; SUPEROXIDE; ANTIFUNGAL AGENT;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CELLULAR STRESS RESPONSE; CITRIC ACID CYCLE; CONTROLLED STUDY; DRUG TOLERANCE; FUNGUS GROWTH; GLYCOLYSIS; LIQUID CHROMATOGRAPHY; METABOLIC REGULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; DRUG EFFECTS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS;

EID: 84942287915     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00543-15     Document Type: Article

References (60)

1. Brown GD, Denning DW, Levitz SM. 2012. Tackling human fungal infections. Science 336:647. http://dx.doi.org/10.1126/science.1222236.
2. Goffeau A. 2008. Drug resistance: the fight against fungi. Nature 452:541-542. http://dx.doi.org/10.1038/452541a.
3. Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62:10-24. http://dx.doi.org/10.1099/jmm.0.045054-0.
4. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95-108. http://dx.doi.org/10.1038/nrmicro821.
5. Fanning S, Mitchell AP. 2012. Fungal biofilms. PLoS Pathog 8:e1002585. http://dx.doi.org/10.1371/journal.ppat.1002585.
6. Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP. 2008. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother 52:3259-3266. http://dx.doi.org/10.1128/AAC.00541-08.
7. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385-5394. http://dx.doi.org/10.1128/JB.183.18.5385-5394.2001.
8. Seneviratne CJ, Wang Y, Jin L, Wong SS, Herath TD, Samaranayake LP. 2012. Unraveling the resistance of microbial biofilms: has proteomics been helpful? Proteomics 12:651-665. http://dx.doi.org/10.1002/pmic.201100356.
9. Taff HT, Mitchell KF, Edward JA, Andes DR. 2013. Mechanisms of Candida biofilm drug resistance. Future Microbiol 8:1325-1337. http://dx.doi.org/10.2217/fmb.13.101.
10. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48-56. http://dx.doi.org/10.1038/nrmicro1557.
11. Cohen NR, Lobritz MA, Collins JJ. 2013. Microbial persistence and the road to drug resistance. Cell Host Microbe 13:632-642. http://dx.doi.org/10.1016/j.chom.2013.05.009.
12. Bigger JW. 1944. Treatment of staphylococcal infections with penicillin. Lancet 244:497-500.
13. Brooun A, Liu S, Lewis K. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 44:640-646. http://dx.doi.org/10.1128/AAC.44.3.640-646.2000.
14. Harrison JJ, Ceri H, Roper NJ, Badry EA, Sproule KM, Turner RJ. 2005. Persister cells mediate tolerance to metal oxyanions in Escherichia coli. Microbiology 151:3181-3195. http://dx.doi.org/10.1099/mic.0.27794-0.
15. Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, Guerardel Y, Alahari A, Kremer L, Jacobs WR, Jr, Hatfull GF. 2008. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69:164-174. http://dx.doi.org/10.1111/j.1365-2958.2008.06274.x.
16. Fauvart M, De Groote VN, Michiels J. 2011. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 60:699-709. http://dx.doi.org/10.1099/jmm.0.030932-0.
17. LaFleur MD, Kumamoto CA, Lewis K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 50:3839-3846. http://dx.doi.org/10.1128/AAC.00684-06.
18. Bink A, Vandenbosch D, Coenye T, Nelis H, Cammue BP, Thevissen K. 2011. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob Agents Chemother 55:4033-4037. http://dx.doi.org/10.1128/AAC.00280-11.
19. Al-Dhaheri RS, Douglas LJ. 2008. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 52:1884-1887. http://dx.doi.org/10.1128/AAC.01473-07.
20. Balaban NQ, Gerdes K, Lewis K, McKinney JD. 2013.A problem of persistence: still more questions than answers? Nat Rev Microbiol 11:587-591. http://dx.doi.org/10.1038/nrmicro3076.
21. Seneviratne CJ, Wong SS, Yuen KY, Meurman JH, Pärnänen P, Vaara M, Samaranayake LP. 2011. Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland. Mycopathologia 172:389-395. http://dx.doi.org/10.1007/s11046-011-9444-4.
22. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126-138. http://dx.doi.org/10.1016/j.cell.2011.10.048.
23. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP. 2009. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol 54:1052-1060. http://dx.doi.org/10.1016/j.archoralbio.2009.08.002.
24. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP. 2008. Candida albicans biofilm formation is associated with increased antioxidative capacities. Proteomics 8:2936-2947. http://dx.doi.org/10.1002/pmic.200701097.
25. Rappsilber J, Mann M, Ishihama Y. 2007. Protocol for micropurification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2:1896-1906. http://dx.doi.org/10.1038/nprot.2007.261.
26. Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367-1372. http://dx.doi.org/10.1038/nbt.1511.
27. Cox J, Mann M. 2012. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 13(Suppl 16):S12.
28. Maere S, Heymans K, Kuiper M. 2005. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21:3448-3449. http://dx.doi.org/10.1093/bioinformatics/bti551.
29. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339:62-66. http://dx.doi.org/10.1016/S0304-3940(02)01423-4.
30. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF. 2009. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37:e45. http://dx.doi.org/10.1093/nar/gkp045.
31. Baginski M, Sternal K, Czub J, Borowski E. 2005. Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic. Acta Biochim Pol 52:655-658.
32. Sokol-Anderson ML, Brajtburg J, Medoff G. 1986. Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 154:76-83. http://dx.doi.org/10.1093/infdis/154.1.76.
33. LaFleur MD, Qi Q, Lewis K. 2010. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother 54:39-44. http://dx.doi.org/10.1128/AAC.00860-09.
34. Barlow GD, Nathwani D. 2000. Sequential antibiotic therapy. Curr Opin Infect Dis 13:599-607. http://dx.doi.org/10.1097/00001432-200012000-00004.
35. Taccetti G, Campana S, Neri AS, Boni V, Festini F. 2008. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis. J Chemother 20:166-169. http://dx.doi.org/10.1179/joc.2008.20.2.166.
36. Chen F, Zheng N, Wang Y, Wen JL, Tu WF, Du YQ, Lin JM. 2013. Sequential intravenous/oral moxifloxacin monotherapy for complicated skin and skin structure infections: a meta-analysis of randomised controlled trials. Int J Clin Pract 67:834-842. http://dx.doi.org/10.1111/ijcp.12174.
37. Hayden HS, Lim R, Brittnacher MJ, Sims EH, Ramage ER, Fong C, Wu Z, Crist E, Chang J, Zhou Y, Radey M, Rohmer L, Haugen E, Gillett W, Wuthiekanun V, Peacock SJ, Kaul R, Miller SI, Manoil C, Jacobs MA. 2012. Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One 7:e36507. http://dx.doi.org/10.1371/journal.pone.0036507.
38. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192:6191-6199. http://dx.doi.org/10.1128/JB.01651-09.
39. Allison KR, Brynildsen MP, Collins JJ. 2011. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216-220. http://dx.doi.org/10.1038/nature10069.
40. Rinnerthaler M, Jarolim S, Heeren G, Palle E, Perju S, Klinger H, Bogengruber E, Madeo F, Braun RJ, Breitenbach-Koller L, Breitenbach M, Laun P. 2006. MMI1 (YKL056c, TMA19), the yeast orthologue of the translationally controlled tumor protein (TCTP) has apoptotic functions and interacts with both microtubules and mitochondria. Biochim Biophys Acta 1757:631-638. http://dx.doi.org/10.1016/j.bbabio.2006.05.022.
41. Bommer UA, Thiele BJ. 2004. The translationally controlled tumour protein (TCTP). Int J Biochem Cell Biol 36:379-385. http://dx.doi.org/10.1016/S1357-2725(03)00213-9.
42. Vediyappan G, Rossignol T, d'Enfert C. 2010. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother 54:2096-2111. http://dx.doi.org/10.1128/AAC.01638-09.
43. Kwan BW, Valenta JA, Benedik MJ, Wood TK. 2013. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother 57:1468-1473. http://dx.doi.org/10.1128/AAC.02135-12.
44. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625. http://dx.doi.org/10.1126/science.1099390.
45. Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K, Brennan RG. 2009. Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323:396-401. http://dx.doi.org/10.1126/science.1163806.
46. Dunn MF, Ramirez-Trujillo JA, Hernandez-Lucas I. 2009. Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology 155:3166-3175. http://dx.doi.org/10.1099/mic.0.030858-0.
47. Lorenz MC, Fink GR. 2001. The glyoxylate cycle is required for fungal virulence. Nature 412:83-86. http://dx.doi.org/10.1038/35083594.
48. Van Acker H, Sass A, Bazzini S, De Roy K, Udine C, Messiaen T, Riccardi G, Boon N, Nelis HJ, Mahenthiralingam E, Coenye T. 2013. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One 8:e58943. http://dx.doi.org/10.1371/journal.pone.0058943.
49. Santoro MG. 2000. Heat shock factors and the control of the stress response. Biochem Pharmacol 59:55-63. http://dx.doi.org/10.1016/S0006-2952(99)00299-3.
50. Cowen LE, Lindquist S. 2005. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309:2185-2189. http://dx.doi.org/10.1126/science.1118370.
51. Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE. 2009. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5:e1000532. http://dx.doi.org/10.1371/journal.ppat.1000532.
52. Mayer FL, Wilson D, Jacobsen ID, Miramon P, Slesiona S, Bohovych IM, Brown AJ, Hube B. 2012. Small but crucial: the novel small heat shock protein Hsp21 mediates stress adaptation and virulence in Candida albicans. PLoS One 7:e38584. http://dx.doi.org/10.1371/journal.pone.0038584.
53. Mayer FL, Wilson D, Hube B. 2013. Hsp21 potentiates antifungal drug tolerance in Candida albicans. PLoS One 8:e60417. http://dx.doi.org/10.1371/journal.pone.0060417.
54. Fiori A, Kucharikova S, Govaert G, Cammue BP, Thevissen K, Van Dijck P. 2012. The heat-induced molecular disaggregase Hsp104 of Candida albicans plays a role in biofilm formation and pathogenicity in a worm infection model. Eukaryot Cell 11:1012-1020. http://dx.doi.org/10.1128/EC.00147-12.
55. Liu Y, Filler SG. 2011. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 10:168-173. http://dx.doi.org/10.1128/EC.00279-10.
56. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71:4333-4340. http://dx.doi.org/10.1128/IAI.71.8.4333-4340.2003.
57. Nailis H, Vandenbosch D, Deforce D, Nelis HJ, Coenye T. 2010. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Res Microbiol 161:284-292. http://dx.doi.org/10.1016/j.resmic.2010.02.004.
58. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, McKay G, Siehnel R, Schafhauser J, Wang Y, Britigan BE, Singh PK. 2011. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334:982-986. http://dx.doi.org/10.1126/science.1211037.
59. Kim JH, Faria NC, Martins Mde L, Chan KL, Campbell BC. 2012. Enhancement of antimycotic activity of amphotericin B by targeting the oxidative stress response of Candida and cryptococcus with natural dihydroxybenzaldehydes. Front Microbiol 3:261.
60. Hoehamer CF, Cummings ED, Hilliard GM, Rogers PD. 2010. Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Antimicrob Agents Chemother 54:1655-1664. http://dx.doi.org/10.1128/AAC.00756-09.